Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic LeukemiaKathryn G. Roberts, Timothy P. Hughes, Jing Ma et al.|New England Journal of Medicine|2014Cited by 1.4k
Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232Eric Larsen, William L. Carroll, Meenakshi Devidas et al.|Journal of Clinical Oncology|2016Cited by 380
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children’s Oncology Group study AALL0232Michael J. Borowitz, Eric Larsen, Brent L. Wood et al.|Blood|2015Cited by 356
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALLBrent L. Wood, Ilan Kirsch, David Wu et al.|Blood|2017Cited by 227
Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic studyTakaya Moriyama, Jun J. Yang, Monika L. Metzger et al.|The Lancet Oncology|2015Cited by 210